Buy Federal Bank, Glenmark, Divis Laboratories: Yogesh Mehta

Yogesh Mehta of Motilal Oswal Securities told CNBC-TV18, "We are looking at future segment and looking at Federal Bank to buy. Yesterday, it had broken out of the level of Rs 80 with decisive volumes and strong break out. We are looking at Rs 92 as the target keeping a stop loss of Rs 80.""In Glenmark Pharma, we are recommending a buy with a stop loss of Rs 880 in the future segment and looking at a target of Rs 980. Probably, the stock will open with a gap today, but then also Rs 980 is the decent upside, so accordingly one can trade," he said."Yesterday, Divis Laboratories gave a strong move and after a fall and consolidation for a few sessions. With Rs 715 as the stop loss, one can go long and target could be Rs 760."